This campaign has been commissioned by an international Japanese pharmaceutical company who combat diseases using a combination of ground‑breaking technology and biology, with an extensive track record of academic collaboration. They are seeking novel research programs which can induce tissue/antigen‑specific regulatory T cells in vivo for immune disorders.
Specific Points of Interest
- Biology that can induce tissue or antigen specific regulatory T cells in vivo. In addition to Treg cell number, it is preferable to have functional data of induced Tregs ...